Shang-Poa Chang

发表

Parallel synthesis enablement of 2-pyridyl-5-cyano-pyrimidine-6-ones—a novel class of HIF-hydroxylase inhibitors

R. Maguire, C. Subramanyam, W. Hungerford, 2010 .

Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE-224,535.

A. Kalgutkar, C. Gabel, R. Shepard, 2011, Bioorganic & medicinal chemistry letters.

Discovery, synthesis and SAR of azinyl- and azolylbenzamides antagonists of the P2X₇ receptor.

C. Gabel, R. Shepard, D. Perregaux, 2011, Bioorganic & medicinal chemistry letters.

Cyclic homopentapeptides 1. Analogs of tuberactinomycins and capreomycin with activity against vancomycin-resistant enterococci and Pasteurella

S. Miller, J. Lyssikatos, M. Lemay, 1997 .

Solid-phase synthesis of peptidyl α-keto heterocycles

C. Subramanyam, Shang-Poa Chang, 2002 .

Cyclic homopentapeptides 2. Synthetic modifications of viomycin

J. Lyssikatos, L. Gerald, J. Clancy, 1997 .

Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.

D. Danley, J. Pandit, E. Laird, 2005, Bioorganic & medicinal chemistry letters.

Solid-phase synthesis of 1,3-diamino ketones

C. Subramanyam, Shang-Poa Chang, 2000 .

Hydrocortisone production using whole-cell biocatalysts in recombinant Escherichia coli

Mingxin Liu, Shang-Poa Chang, Wei Tian, 2023, Biochemical Engineering Journal.

Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor

J. O’Shea, A. Milici, B. Reitz, 2003, Science.